The Institut Curie hospital group is a renowned cancer hospital in France. Established in 1921, by Marie Curie, Institut Curie’s main mission are care, research, and the transfer and preservation of knowledge. The institute is popular for its world-class multidisciplinary research center that combines research in genetics, immunology, cell biology, epigenetics, soft matter physics, medicinal and organic chemistry.
The facility has over 3,300 technicians, physicians, researchers, clinicians, and caregivers operating in three locations: Paris, Saint-Cloud, and Orsay. Institute Curie is a leader in the fight against cancer and is equipped with state-of-the-art cancer research facilities that include: a unique experimental radiotherapy platform, antibody technologies, animal housing, advanced imaging, cytometry, bioinformatics, and many more.
Besides, Institute Curie’s proximity favors accessibility to massive sample collections and clinical databases, as well as translational research. The institute is a founding member of PSL University, and thus, has access to many technical facilities, privileged connections with all others members as well as funding sources.
According to its website: (https://institut-curie.org/), the facility has the status of a private health institution of public interest (ESPIC) that enables the institute to enjoy resources that come from the French national health insurance fund. The status also enables the institute to contribute to missions that benefit the public interests such as innovation and clinical research and teaching all based on a flat rate allowance scheme for each mission.
Activities at the facility are developed in conjunction with research organizations such as universities, Inserm, and CNRS. These organizations pay part of the cost for technicians, engineers, researchers as well as the administrative staff. In addition, these organizations also cater for some investment and operating expenses.
Furthermore, Institut Curie’s research center benefits from an annual subsidy offered by the French Ministry of Higher Education to support the institute’s research efforts. It also receives resources via competitive national and foreign calls for tenders.
As stated on its website, the treatment process at the cancer hospital in Paris and other sites is customized to each patient with all the supportive care required to be personalized for the patients.
Comments are closed